3 Hiring Risks Biopharma Employers Overlook  | View as HTML Post Jobs Search Resumes Email Preferences
BioSpaceLike Us on FacebookFollow us on TwitterLinkedInRSSSubscribe
   DEAL OF THE MONTH

Maximize your exposure to job seekers through job alerts sent to over 30,000 job seekers every day. Buy two weeks of Job Alert banner advertising and receive two weeks free, a savings of $1,995! Offer valid through January 21st by mentioning the promo code: FreeJobAlertAd

   RECRUITER RESOURCES
Your Career

3 Hiring Risks Biopharma Employers Overlook

A senior analytical chemist retires. A research associate moves to another state. A quality control manager takes a position with a competitor. A vendor cancels a contract. Whatever the reason, there’s now a hole to fill – and you need to do it with the best possible candidate in the least amount of time. Read More.

 
Your Career

Don't Post a Job, Advertise Respect

Job postings are now routinely used on both job boards and social media sites. These online communications remain the most widespread method of candidate sourcing, yet are disparaged and ignored at almost every recruitment conference. Read More.

 
   PRODUCT HIGHLIGHT
When you're hiring for multiple positions, BioSpace can save you hours of time and effort with our automated job postings. A Job Wrap comes with multiple benefits including exponential exposure of jobs through refreshes to the top of the list and job alert inclusions, and the best part is, it's maintenance free!

For more information about this productand other recruitment and advertising solutions, contact Biospace at (888) BIOSPACE or support@biospace.com today!
   IN THE NEWS
Bristol-Myers Squibb Company (BMY), Pfizer Inc. (PFE), Merck & Co., Inc. (MRK) Ready to Buy Again; $10 Billion Deals Seen Returning in 2013
Get ready for the return of the $10 billion-plus drug deal. Pharmaceutical companies including Pfizer Inc. (PFE) and Bristol- Myers Squibb Co. (BMY) have spent the last several years digesting earlier acquisitions, refocusing their product development and setting aside cash in anticipation of expiring patents. Learn More »
GlaxoSmithKline (GSK) Future Hangs in Balance on 2013 U.S. Drug Approvals
It's a make or break year for GlaxoSmithKline Plc. (GSK) The U.K.'s largest pharmaceutical company is counting on a spate of drugs winning approval this year to reverse recent setbacks and revive growth. Learn More »
Will the Novartis AG (NVS) CEO Have to Take a Pay Cut?
Many people may complain about the gap between ceo compensation and the rest of the world, but the Swiss are doing more than grumbling. Learn More »

Post Your:   News   |   Jobs   |   Company Profile   |   Event   |   Advertising/Sponsorship

This email was sent by BioSpace.com. Please distribute this e-cast freely. Subscribe to our newsletter. To unsubscribe or update your email preferences, click here. This request may take up to 10 business days to take effect.

BioSpace.com is an onTargetjobs, Inc. company and respects your time and privacy. BioSpace.com is not responsible for offers, products, services, or other information expressed or made available by third parties and provided by any off-site Internet page referenced through this email's hypertext. While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. To guarantee receipt of BioSpace.com emails, add newsletters@email.biospace.com to your address book.

Contact the News Team Email: news@biospace.com; Toll Free: (877) 277-7585; 6465 S. Greenwood Plaza Blvd., Ste. 400, Centennial, CO 80111
Send questions and comments to the BioSpace News Beat Team.
Editor & Publisher: Lana Ho
Editorial & Production Staff: Maysa Darwish, Tammy Liu

© 2012 onTargetjobs, Inc. All rights reserved. BioSpace.com is a registered trademark of onTargetjobs, Inc. All other trademarks and registered trademarks are the property of their respective owners.